Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders

This study has been completed.
Korea Otsuka Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Kyooseob Ha, Seoul National University Bundang Hospital Identifier:
First received: February 14, 2009
Last updated: December 4, 2013
Last verified: December 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)